Blood Draw Study for Liver Transplant Patients

Immunomonitoring of Transplant Patients

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Inclusion Criteria:

• Received a liver Transplant

Exclusion Criteria:

• Received Multiple Organ Transplant